Warning! GuruFocus detected
2 Severe warning signs
with BIO.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
New Key Statistics Module, Z-Score and F-Score
NYSE:BIO Key Ratios
Market Cap $ M | 6,684.93 |
Enterprise Value $ M | 6,464.86 |
P/E(ttm) | -- |
PE Ratio without NRI | 23.29 |
Forward PE Ratio | 25.02 |
Price/Book | 1.02 |
Price/Sales | 2.65 |
Price/Free Cash Flow | 25.38 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 2,566.00 |
EPS (TTM) $ | -65.04 |
Beneish M-Score | -2.52 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -2.82 |
EV-to-EBITDA | -3.02 |
PEG | -- |
Shares Outstanding M | 28.01 |
Net Margin (%) | -71.86 |
Operating Margin % | 10.48 |
Pre-tax Margin (%) | -91.27 |
Quick Ratio | 4.85 |
Current Ratio | 6.48 |
ROA % (ttm) | -16.90 |
ROE % (ttm) | -23.87 |
ROIC % (ttm) | 2.36 |
Dividend Yield % | -- |
Altman Z-Score | 2.35 |
BIO Number of Guru Trades
BIO Volume of Guru Trades
Gurus Latest Trades with NYSE:BIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:BIO is held by these investors
Total 7
Bio-Rad Laboratories Inc Insider Transactions
No Available Data
News about NYSE:BIO
Total 0- 1